Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jul 25:2018:2361963.
doi: 10.1155/2018/2361963. eCollection 2018.

The Immunologic Role of Gut Microbiota in Patients with Chronic HBV Infection

Ruilin Yang  1 , Yao Xu  1 , Zhifeng Dai  1 , Xuhong Lin  1 , Huichao Wang  2
Affiliations
Review

The Immunologic Role of Gut Microbiota in Patients with Chronic HBV Infection

Ruilin Yang et al. J Immunol Res. .

Abstract

Hepatitis B can cause acute or chronic liver damage due to hepatitis B virus (HBV) infection. Cirrhosis or hepatocellular carcinoma (HCC) caused by chronic HBV infection often leads to increased mortality. However, the gut and liver have the same embryonic origin; therefore, a close relationship must exist in terms of anatomy and function, and the gut microbiota plays an important role in host metabolic and immune modulation. It is believed that structural changes in the gut microbiota, bacterial translocation, and the resulting immune injury may affect the occurrence and development of liver inflammation caused by chronic HBV infection based on the in-depth cognition of the concept of the "gut-liver axis" and the progress in intestinal microecology. This review aims to summarize and discuss the immunologic role of the gut microbiota in chronic HBV infection.

PubMed Disclaimer

References

    1. World Health Organization. Global Hepatitis Report 2017. WHO; 2017. http://www.who.int/hepatitis.
    1. Beckebaum S., Malagó M., Dirsch O., et al. Efficacy of combined lamivudine and adefovir dipivoxil treatment for severe HBV graft reinfection after living donor liver transplantation. Clinical Transplantation. 2003;17(6):554–559. doi: 10.1046/j.0902-0063.2003.00097.x. - DOI - PubMed
    1. Castelnau C., le Gal F., Ripault M. P., et al. Efficacy of peginterferon alpha-2b in chronic hepatitis delta: relevance of quantitative RT-PCR for follow-up. Hepatology. 2006;44(3):728–735. doi: 10.1002/hep.21325. - DOI - PubMed
    1. Hartmann P., Chen W. C., Schnabl B. The intestinal microbiome and the leaky gut as therapeutic targets in alcoholic liver disease. Frontiers in Physiology. 2012;3:p. 402. doi: 10.3389/fphys.2012.00402. - DOI - PMC - PubMed
    1. Lin R., Zhou L., Zhang J., Wang B. Abnormal intestinal permeability and microbiota in patients with autoimmune hepatitis. International Journal of Clinical and Experimental Pathology. 2015;8(5):5153–5160. - PMC - PubMed

MeSH terms

LinkOut - more resources